ACTRN12611001119987
Terminated
未知
Antibody responses to influenza vaccination in the elderly: effects of a brief bout of weight-lifting exercise versus quiet rest immediately before vaccination
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Advanced age
- Sponsor
- niversity of Sydney
- Enrollment
- 96
- Status
- Terminated
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Aged 65 years or older.
Exclusion Criteria
- •History of vaccine related allergies or side\-effects; allergy to any constituent of the vaccine (including eggs and chicken); current immune disorder (including rheumatoid arthritis and asthma) or acute infection; current steroid or anticoagulant medication, any joint injury or pain which restricts completion of the exercise task, or recent history (6 months prior) of strength training
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-ESGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-CZGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibEUCTR2017-003055-30-PLGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibEUCTR2017-003055-30-FRGilead Sciences, Inc.22
Active, not recruiting
Phase 1
Evaluation of how body's defense system against infection responds to the flu vaccine in cancer patients being treated with idelalisibTo assess the immune response to an influenza vaccine in subjects with B-cell malignancies treated with idelalisibMedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003055-30-GBGilead Sciences, Inc.22